Michael D. Lockshin, MD
Dr. Lockshin graduated from Harvard College and Harvard Medical School; he did his residencies at Second (Cornell) Medical Service at Bellevue Hospital and Memorial-Sloan Kettering Hospital, and his rheumatology fellowship at Columbia-Presbyterian Hospital. A member of the faculty of Cornell Medical College and a staff rheumatologist at Hospital for Special Surgery and New York Hospital from the 1970s to 1989, he became Extramural Director, then Acting Director of the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases in 1989. He returned to Hospital for Special Surgery in April 1997, and is now the director of the Barbara Volcker Center for Women and Rheumatic Disease at Hospital for Special Surgery and professor of medicine and obstetrics-gynecology at Weill-Cornell Medical College. He is the author of nearly 300 research papers, book chapters, and books, most on the topic of lupus, pregnancy, antiphospholipid syndrome, and sex differences in disease.
Appointments
Professor of Medicine and OB-GYN, Weill Medical College of Cornell University
Attending Physician, Hospital for Special Surgery
Director, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery
Co-Director, Mary Kirkland Center for Lupus Research, Hospital for Special Surgery
Specialty
Rheumatology
Certification
Internal Medicine, 1969
Rheumatology, 1972
Chairman, Rheumatology Subspecialty Board, 1983-86
State Licensure
New York
Education
MD, 1963, Harvard Medical School, Cambridge, Massachusetts, US
Residency
Second (Cornell) Medical Service, US
Bellevue Hospital, US
Memorial Sloan-Kettering Hospital, US
Fellowship
Columbia-Presbyterian Medical Center, US
Michael D. Lockshin, MD is the author of the following articles on HSS.edu:
For Patients
For Professionals
Special Expertise
Gender and rheumatic disease
Pregnancy and rheumatic disease
Antiphospholipid antibody syndrome
Neurological SLE
Awards
Various national offices, national and international visiting professorships.
Institute of Medicine Committee
Selected Publications
For more publications, please see the
PubMed listing.
Clinical Trials
- Cognitive Dysfunction, Diffusion Tensor Imaging and Functional Magnetic Resonance Imaging (MRI) in Antiphospholipid Antibody (aPL)-negative Systemic Lupus Erythematosus (SLE) versus aPL-positive non-SLE Patients
- Effects of Fluvastatin on Proinflammatory and Prothrombotic markers in Antiphospholipid Syndrome
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 Week Study to Evaluate the Efficacy and Safety of Belimumab (GHS1006, LymphoStat-B), A fully Human monoclonal Anti-BlyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE).
- RITAPS: A Pilot Study Of Rituximab For The Anticoagulation-Resistant Manifestations Of Antiphospholipid Syndrome (APS)
- Cognitive Function in SLE
- Pilot and Feasibility Study of Modafinil Treatment to Improve Cognitive Efficiency in SLE Patients
- PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE)
- LUNAR: A phase III, randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy and safety of rituximab in subjects with class III or IV lupus nephritis
- EXPLORER: A randomized, double-blind, placebo controlled, multicenter, phase II/III study to evaluate the efficacy and safety of rituximab in subjects with moderate to severe systemic lupus erythematosus
Specialized Centers
Barbara Volcker Center for Women and Rheumatic Diseases
